Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 31 entries
Sorted by: Best Match Show Resources per page
Guillain-Barre or CIDP? That is the question.

Neurology

Smith BE.
PMID: 20445150
Neurology. 2010 May 25;74(21):1664-5. doi: 10.1212/WNL.0b013e3181e3d959. Epub 2010 May 05.

No abstract available.

[Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic strategy. Guidelines of the French CIDP study group].

Revue neurologique

Antoine JC, Azulay JP, Bouche P, Créange A, Fournier E, Gallouedec G, Lagueny A, Lefaucheur JP, Léger JM, Magy L, Maisonobe T, Nicolas G, Pouget J, Soichot P, Stojkovic T, Vallat JM, Verschueren A, Vial C, Viala K.
PMID: 16365632
Rev Neurol (Paris). 2005 Oct;161(10):988-96. doi: 10.1016/s0035-3787(05)85166-5.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) comprises a group of dysimmune neuropathies easily diagnosed in more than half of the patients. Diagnosis is based on clinical, electrophysiological and biological clues. In some patients, diagnosis is unclear because of the debated...

Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment.

Journal of the neurological sciences

Cornblath DR, Gorson KC, Hughes RA, Merkies IS.
PMID: 23663896
J Neurol Sci. 2013 Jul 15;330(1):2-3. doi: 10.1016/j.jns.2013.04.015. Epub 2013 May 08.

No abstract available.

Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Revue neurologique

Guimarães-Costa R, Iancu Ferfoglia R, Viala K, Léger JM.
PMID: 25200479
Rev Neurol (Paris). 2014 Oct;170(10):595-601. doi: 10.1016/j.neurol.2014.06.002. Epub 2014 Sep 04.

Chronic idiopathic demyelinating polyradiculoneuropathy (CIDP) is a rare disease, the most frequent one within the spectrum of the so-called "chronic immune-mediated neuropathies". Challenges in the treatment of CIDP firstly concern its diagnosis, which may be difficult, mainly for the...

Reply: biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.

Brain : a journal of neurology

Park SB, Sung JY, Tani J, Kiernan MC, Lin CS.
PMID: 25183715
Brain. 2015 Mar;138:e336. doi: 10.1093/brain/awu254. Epub 2014 Sep 02.

No abstract available.

Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Neuroepidemiology

Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC.
PMID: 30669140
Neuroepidemiology. 2019;52(3):161-172. doi: 10.1159/000494291. Epub 2019 Jan 22.

BACKGROUND: Prevalence and incidence rates of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are required to determine the impact of CIDP on society. We aimed to estimate the prevalence and incidence of CIDP worldwide and to determine the effect of diagnostic...

History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Mayo Clinic proceedings

Dyck PJB, Tracy JA.
PMID: 29866282
Mayo Clin Proc. 2018 Jun;93(6):777-793. doi: 10.1016/j.mayocp.2018.03.026.

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is probably the best recognized progressive immune-mediated peripheral neuropathy. It is characterized by a symmetrical, motor-predominant peripheral neuropathy that produces both distal and proximal weakness. Large-fiber abnormalities (weakness and ataxia) predominate, whereas small-fiber abnormalities...

Burden of illness in chronic inflammatory demyelinating polyneuropathy: some facts and solutions.

Journal of neurology

Rajabally YA.
PMID: 32715395
J Neurol. 2020 Oct;267(10):3092-3093. doi: 10.1007/s00415-020-10101-4. Epub 2020 Jul 27.

No abstract available.

Burden of illness in chronic inflammatory demyelinating polyneuropathy: some clarifications.

Journal of neurology

Querol L, Crabtree M, Herepath M, Priedane E, Viejo-Viejo I, Agush S, Sommerer P.
PMID: 32728947
J Neurol. 2020 Oct;267(10):3094-3095. doi: 10.1007/s00415-020-10115-y. Epub 2020 Jul 29.

No abstract available.

Determinants of Outcome in Chronic Inflammatory Demyelinating Polyneuropathy: A Longitudinal Study.

Journal of clinical neuromuscular disease

Manikyanahalli Siddegowada P, Singh RK, Prasad K, Srivastava AK, Shukla G, Vibha D.
PMID: 34808655
J Clin Neuromuscul Dis. 2021 Dec 01;23(2):111-112. doi: 10.1097/CND.0000000000000351.

No abstract available.

Incomplete intestinal obstruction as an initial and persistent presentation in chronic inflammatory demyelinating polyneuropathy: A case report.

Medicine

Wang L, Yuan XZ, Zhao XM, Wang FY, Wang Y.
PMID: 30544461
Medicine (Baltimore). 2018 Dec;97(49):e13538. doi: 10.1097/MD.0000000000013538.

RATIONALE: Autonomic symptoms are not uncommon in chronic inflammatory demyelinating polyneuropathy (CIDP), but they are mostly mild and transient and are overshadowed by somatic manifestations. Here, we report a very unusual case of CIDP with severe autonomic symptom, intestinal...

[Recent topics of chronic inflammatory demyelinating polyneuropathy].

Rinsho shinkeigaku = Clinical neurology

Iijima M.
PMID: 23196467
Rinsho Shinkeigaku. 2012;52(11):917-9. doi: 10.5692/clinicalneurol.52.917.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated polyradiculoneuropathy. The American Academy of Neurology criteria has been used widely in diagnoses, and has generated clinical and pathological information. Recently, the EFNS/PNS criteria revised the concept of conventional "typical...

Showing 1 to 12 of 31 entries